Search hospitals > Arizona > Phoenix
Banner - University Medical Center Phoenix
Claim this profilePhoenix, Arizona 85006
Global Leader in Atrial Fibrillation
Global Leader in Aortic Valve Stenosis
Conducts research for Cancer
Conducts research for Heart Failure
Conducts research for Aortic Stenosis
204 reported clinical trials
24 medical researchers
Summary
Banner - University Medical Center Phoenix is a medical facility located in Phoenix, Arizona. This center is recognized for care of Atrial Fibrillation, Aortic Valve Stenosis, Cancer, Heart Failure, Aortic Stenosis and other specialties. Banner - University Medical Center Phoenix is involved with conducting 204 clinical trials across 320 conditions. There are 24 research doctors associated with this hospital, such as Michael Morris, MD, Shakeela Bahadur, Marvin Eng, MD, and Radha Gopalan, MD.Top PIs
Michael Morris, MDMemorial Sloan Kettering Cancer Center1 year of reported clinical research
Studies Prostate Cancer
Studies Tumors
12 reported clinical trials
18 drugs studied
Shakeela BahadurBanner MD Anderson Cancer Center5 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
11 reported clinical trials
29 drugs studied
Marvin Eng, MDHenry Ford Hospital5 years of reported clinical research
Studies Mitral Valve Regurgitation
Studies Mitral Valve Disease
7 reported clinical trials
14 drugs studied
Radha Gopalan, MDBanner University Medical Center Phoenix6 years of reported clinical research
Studies Heart Failure
Studies Congestive Heart Failure
5 reported clinical trials
6 drugs studied
Clinical Trials running at Banner - University Medical Center Phoenix
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Atrial Fibrillation
Mitral Valve Regurgitation
COVID-19
Cardiovascular Disease
Obesity
Post-COVID Syndrome
Long COVID Syndrome
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Banner - University Medical Center Phoenix?
Banner - University Medical Center Phoenix is a medical facility located in Phoenix, Arizona. This center is recognized for care of Atrial Fibrillation, Aortic Valve Stenosis, Cancer, Heart Failure, Aortic Stenosis and other specialties. Banner - University Medical Center Phoenix is involved with conducting 204 clinical trials across 320 conditions. There are 24 research doctors associated with this hospital, such as Michael Morris, MD, Shakeela Bahadur, Marvin Eng, MD, and Radha Gopalan, MD.